产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
生化/生理作用
富马酸替诺福韦酯是替诺福韦的一种前药，一种可引起DNA转录提前终止的核苷酸类似物逆转录酶抑制剂(nRTI)。在T细胞系和原代血淋巴细胞中，替诺福韦酯的抗病毒活性是替诺福韦的100倍以上，原因就在于其快速的细胞间摄取。富马酸替诺福韦酯在HIV/AIDS和慢性乙肝病毒感染的预防和治疗中已被单独和经多种联合使用，并位于国际卫生组织的基本药品清单中。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAB2763 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
| 经验(实验)分子式 | C19H30N5O10P · C4H4O4 |
| 分子量 | 635.51 |
| MDL编号 | MFCD08141829 |
| NACRES | NA.24 |
产品性质
| 质量水平 | 300 |
| 等级 | certified reference material pharmaceutical secondary standard |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 500 mg |
| application(s) | pharmaceutical |
| 格式 | neat |
| 药典可追溯性 | traceable to USP 1643656 |
| 储存温度 | 2-8℃ |
| SMILES string | OC(/C=C/C(O)=O)=O.NC1=C2C(N(C[C@@H](C)OCP(OCOC(OC(C)C)=O)(OCOC(OC(C)C)=O)=O)C=N2)=NC=N1 |
| InChI | 1S/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t14-;/m1./s1 |
| InChI key | VCMJCVGFSROFHV-WZGZYPNHSA-N |
安全信息
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
SUPELCO
m.cnreagent.com
